Research Article

Advanced Disease Detection and Personalized Medicine: Integrated Data Approaches for Enhanced Parkinson's Disease and Breast Cancer Detection and Treatment in the USA

Authors

  • Bishnu Padh Ghosh School of Business, International American University, Los Angeles, California, USA
  • Proshanta Kumar Bhowmik Department of Business Analytics, Trine University, Angola, IN, USA
  • Mohammad Shafiquzzaman Bhuiyan Doctor of Business Administration, Westcliff University, Irvine, California

Abstract

This present study focuses on integrating data-driven approaches into personalized medicine for better detection and treatment of Parkinson's disease and breast cancer through the US healthcare system. The deeper integration of genomics, clinical records, and patient self-reported data with machine learning algorithms will enhance early disease detection and optimization of treatment pathways. The results show that, more precisely, Random Forest and XGBoost machine learning models hold great promise for considerably improving diagnostic precision and predictive power. This realization opens a door for precision medicine-tailored health services according to the peculiarities of individual patients, which would improve treatment outcomes and encourage preventive healthcare. In addition, this approach aligns with the latest US efforts in precision medicine and contributes to evidence-based transformation in healthcare practice.

Article information

Journal

British Journal of Pharmacy and Pharmaceutical Sciences

Volume (Issue)

1 (2)

Pages

11-30

Published

2024-11-06

How to Cite

Bishnu Padh Ghosh, Proshanta Kumar Bhowmik, & Mohammad Shafiquzzaman Bhuiyan. (2024). Advanced Disease Detection and Personalized Medicine: Integrated Data Approaches for Enhanced Parkinson’s Disease and Breast Cancer Detection and Treatment in the USA. British Journal of Pharmacy and Pharmaceutical Sciences, 1(2), 11–30. https://doi.org/10.32996/jpps.2024.1.2.2

Downloads

Keywords:

Personalized medicine, Parkinson's disease, breast cancer, disease detection, data integration, genomics, machine learning, treatment optimization, USA Healthcare